CSOFT Health Sciences Revenue and Competitors
Estimated Revenue & Valuation
- CSOFT Health Sciences's estimated annual revenue is currently $33.3M per year.
- CSOFT Health Sciences's estimated revenue per employee is $140,000
Employee Data
- CSOFT Health Sciences has 238 Employees.
- CSOFT Health Sciences grew their employee count by 1% last year.
CSOFT Health Sciences's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Global Operations | Reveal Email/Phone |
2 | Senior Client Services Manager | Reveal Email/Phone |
3 | Global Delivery and Operations Manager | Reveal Email/Phone |
CSOFT Health Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 151 | 7% | N/A | N/A |
#2 | $7.5M | 111 | 21% | N/A | N/A |
#3 | $750M | 5152 | -3% | $149.1M | N/A |
#4 | $33.3M | 238 | 1% | N/A | N/A |
#5 | $7.5M | 70 | 8% | N/A | N/A |
#6 | $3.5M | 51 | 21% | N/A | N/A |
#7 | $3.5M | 424 | N/A | N/A | N/A |
#8 | $3.5M | 52 | 2% | N/A | N/A |
#9 | $3.5M | 66 | 27% | N/A | N/A |
#10 | $7.5M | 360 | 23% | $75.2M | N/A |
What Is CSOFT Health Sciences?
Ensuring the availability of personalized, relevant information is a top priority for companies in the health sciences field. While there are many resources available, disseminating public information remains a challenge for many. CSOFT Health Sciences is committed to delivering the highest-grade language solutions to help pharmaceutical, medical device, biotech, and other leaders in the industry change patientᅢᄁ¬ツᆲ¬トᄁs lives globally for the better. For more information visit https://lifesciences.csoftintl.com.
keywords:N/AN/A
Total Funding
238
Number of Employees
$33.3M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $70.7M | 238 | 10% | N/A |
#2 | $53.7M | 238 | 6% | N/A |
#3 | $34M | 238 | -12% | $43M |
#4 | $26.2M | 238 | 16% | N/A |
#5 | $750M | 239 | 22% | N/A |